RUBERTO, Amedeo
 Distribuzione geografica
Continente #
NA - Nord America 1.353
EU - Europa 353
AS - Asia 192
SA - Sud America 26
AF - Africa 22
Totale 1.946
Nazione #
US - Stati Uniti d'America 1.345
IT - Italia 96
SG - Singapore 82
UA - Ucraina 63
SE - Svezia 60
IN - India 58
CN - Cina 46
FI - Finlandia 34
AT - Austria 25
AR - Argentina 24
TG - Togo 20
DE - Germania 19
GB - Regno Unito 13
BE - Belgio 9
FR - Francia 9
CA - Canada 8
RU - Federazione Russa 7
IE - Irlanda 5
NL - Olanda 4
CH - Svizzera 3
BG - Bulgaria 2
CL - Cile 2
IR - Iran 2
JP - Giappone 2
RO - Romania 2
GR - Grecia 1
HU - Ungheria 1
MY - Malesia 1
SA - Arabia Saudita 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 1.946
Città #
Fairfield 202
Chandler 188
Woodbridge 86
Ann Arbor 83
Ashburn 83
Seattle 69
Houston 68
Cambridge 67
Wilmington 60
Singapore 54
Dearborn 40
Jacksonville 33
Plano 33
Princeton 33
Boston 28
Federal 24
Lawrence 24
Vienna 23
Lomé 20
Rome 20
Boardman 19
Beijing 18
San Diego 16
Andover 12
Santa Clara 9
Kunming 8
Brussels 7
Des Moines 7
San Paolo di Civitate 7
Bologna 6
Toronto 6
Milan 5
Millbury 5
Palermo 5
Bremen 4
Bühl 4
Dublin 4
Moscow 4
Nanchang 4
Naples 4
New York 4
Norwalk 4
Chennevières-sur-Marne 3
Cosenza 3
Duisburg 3
Falkenstein 3
Mannheim 3
Melilli 3
Parma 3
Redmond 3
Arak 2
Bruges 2
Buffalo 2
Casalecchio di Reno 2
Falls Church 2
Fidenza 2
Genoa 2
Hefei 2
Militello in Val di Catania 2
Montréal 2
Neuchâtel 2
Ningbo 2
Rocca Priora 2
Sassari 2
Sofia 2
Southend 2
Tappahannock 2
Tokyo 2
Turin 2
Aberdeen 1
Bern 1
Catania 1
Chesterfield 1
Cork 1
Fremont 1
Fuzhou 1
Hebei 1
Helsinki 1
Hounslow 1
Islington 1
Jinan 1
Kilburn 1
London 1
Mascalucia 1
Mcallen 1
Meizhou 1
Miami Beach 1
Palmetto 1
Paris 1
Piscataway 1
Portland 1
Prescot 1
Quzhou 1
Riyadh 1
San Francisco 1
San Mateo 1
Santiago 1
Shah Alam 1
Silverton 1
Simi Valley 1
Totale 1.493
Nome #
A case of social phobia and avoidant personality disorder with erectile dysfunction successfully treated with venlafaxine and add-on reboxetine. 91
Emergency staff reactions to suicidal and self-harming patients. 90
Personality and psychopathological profiles in individuals exposed to mobbing. 83
Suicide in the epilepsies: a meta-analytic investigation of 29 cohorts 83
Alopecia areata with comorbid depression: early resolution with combined paroxetine-triamcinolone treatment 82
Hopelessness and suicide risk emerge in psychiatric nurses suffering from burnout and using specific defense mechanisms 79
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. 72
Hypnopompic hallucinations during olanzapine treatment. 71
Suicide and awareness of illness in schizophrenia: An overview 69
Suicide risk during pregnancy. Comment on "The obstetrician and depression during pregnancy" by Campagne DM [Eur J Obstet Gynecol Reprod Biol 116 (2) (2004) 125-30]. 68
Depressione e malattie cardiovascolari. 67
Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning 67
High lethality suicide attempts among chronic schizophrenia patients 65
Body uneasiness and suicide risk in a non-clinical sample of university students 65
Childhood suicide: A major issue in pediatric health care 64
Toward a new prevention of suicide in schizophrenia 63
Suicide in borderline personality disorder: A meta-analysis 62
Suicide in anorexia nervosa: A meta-analysis 60
Suicide and attempted suicide in eating disorders, obesity and weight-image concern. 59
Ansia e depressione in corso di infezioni da HIV e da HCV: risultati, implicazioni per il rischio di suicidio e prospettive terapeutiche. 59
Stigma e rischio di suicidio. Overview. 59
Postpartum depression without delivering a child? 58
Trends of use of typical antipsychotic drugs in a population of bipolar patients followed in community national mental health clinics 56
Where schizophrenic patients commit suicide: A review of suicide among inpatients and former inpatients 55
Gemelli e psichiatria. 53
Suicidality in DSM IV cluster B personality disorders. An overview 41
Prevenzione del suicidio nella schizophrenia e prospettive riabilitative nel paziente schizofrenico a rischio di suicidio. 40
EFFECTS OF SERTRALINE, ESCITALOPRAM OR VENLAFAXINE TREATMENT ON SERUM BDNF LEVELS IN PATIENTS WITH ANXIETY-DEPRESSIVE DISORDERS 39
Suicide in schizophrenia. What are we going to do about it? 38
L’ansia e la depressione in medicina generale 34
Understanding suicide in schizophrenia: a national imperative for prevention. 30
Suicide in anorexia nervosa and bulimia nervosa. 29
Fobia sociale: approcci terapeutici. 28
Totale 1.979
Categoria #
all - tutte 5.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.705


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020311 0 0 0 0 0 73 67 58 50 32 17 14
2020/2021142 12 31 8 12 2 5 0 18 14 24 12 4
2021/2022357 0 24 34 11 45 5 12 25 40 27 63 71
2022/2023468 74 90 65 75 54 36 10 13 41 0 3 7
2023/2024167 11 37 4 17 11 10 4 18 1 19 19 16
2024/2025125 32 12 18 14 34 15 0 0 0 0 0 0
Totale 1.979